About: Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Delapierre B., Reman O., Dina J., Breuil C., Bellal M., Johnson-Ansah H., Gac C., Damaj G., Chantepie S.. Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation. Current Research in Translational Medicine, Elsevier-Masson SAS, 2019, ⟨10.1016/j.retram.2019.03.001⟩
  • Delapierre B., Reman O., Dina J., Breuil C., Bellal M., Johnson-Ansah H., Gac C., Damaj G., Chantepie S. . Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation . Current Research in Translational Medicine, 2019, ⟨10.1016/j.retram.2019.03.001⟩
Title
  • Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation
dc:date
  • 2019
Digital Object Identifier (DOI)
  • 10.1016/j.retram.2019.03.001
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software